Premium Information is available for this item - Upgrade for $1 a day
6505-00-619-8885
Usp Reserpine Tablets
6505006198885 006198885 RESERP0ID SERPASIL SERPANRAY RAUSED
November 2023
8

Marketplace 6505-00-619-8885
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-619-8885 5+ Documents (More...)
RQST NE Updated Every Day 6505-00-619-8885 RQST Updated Every Day 6505-00-619-8885 RQST NE Related Documents
6505-00-619-8885 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-619-8885
Tablet6505992101702 992101702 RESERP1NETABLETBP 6505008917557 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-619-8885
Usp Reserpine Tablets 6505006198885 006198885 Related Documents 6505-00-619-8885 5+ Documents https
Usp Reserpine Tablets 6505006198885 006198885 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-891
Reserpine Tablets 6505008917557 008917557 RESERP1NETABLETBP 891-7557 6505008917557008917557 6505-00-619-8885
Usp Reserpine Tablets 6505006198885 006198885 891-7557 6505008917557008917557 6505-00-619-8885
7557 5+ Documents ( More https 210-1705 6505-00-290-0022 Reserpine Tablets6505006874454 006874454 SERPASIL
992101702 https 210-1706 6505-99-210-1705 6505-00-290-0022 6505-00-582-5414 6505-00-926-2190 6505-00-619-8885
6505009262190009262190 Documents 210-1706 6505-99-210-1705 6505-00-290-0022 6505-00-582-5414 6505-00-926-2190 6505-00-619-8885
Restrictions 6505-00-619-8885
6505-00-619-8885 is a Usp Reserpine Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-619-8885
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-619-8885
- Part Number
- Manufacturer
- Status
- RESERP0ID
- Manufacturer
- 93703 - Pharmacia & Upjohn Company (Active)
- Incomplete Reference
- Incomplete Reference
- SERPASIL
- 04482 - Ciba-Geigy Corp (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- SERPANRAY
- 18991 - Panray Div (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
- RAUSED
- 78473 - Squibb E R And Sons Inc World Hq (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-00-619-8885
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 1.000 Milligrams Reserpine Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1000.000 Tablets
NATO Stock Numbers Related to 6505-00-619-8885
Freight Information 6505-00-619-8885
6505-00-619-8885 has freight characteristics.. 6505-00-619-8885 has a variance between NMFC and UFC when transported by rail and the description should be consulted.